Diagnosis and management of dysmenorrhoea

被引：307

作者：

Proctor, Michelle

Farquhar, Cynthia

机构：

[1] Univ Auckland, Dept Obstet & Gynaecol, Cochrane Menstrual Disorders & Subfertil Grp, Auckland 1, New Zealand

[2] Univ Auckland, Natl Womens Hosp, Dept Obstet & Gynaecol, Auckland 1, New Zealand

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2006年 / 332卷 / 7550期

关键词：

D O I：

10.1136/bmj.332.7550.1134

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1134 / 1138B

页数：7

共 41 条

[1]

Akin M, 2004, J REPROD MED, V49, P739

[2] Continuous low-level topical heat in the treatment of dysmenorrhea [J].

Akin, MD ;

Weingand, KW ;

Hengehold, DA ;

Goodale, MB ;

Hinkle, RT ;

Smith, RP .

OBSTETRICS AND GYNECOLOGY, 2001, 97 (03) :343-349

[3]

Ali A, 1997, J INT MED RES, V25, P41

[4]

[Anonymous], 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002122

[5] Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena®):: a 3-year follow-up study [J].

Baldaszti, E ;

Wimmer-Puchinger, B ;

Löschke, K .

CONTRACEPTION, 2003, 67 (02) :87-91

[6]

BANDOLIER, VITAMIN E DYSMENORRH

[7] Diet and sex-hormone binding globulin, dysmenorrhea, and premenstrual symptoms [J].

Barnard, ND ;

Scialli, AR ;

Hurlock, D ;

Bertron, P .

OBSTETRICS AND GYNECOLOGY, 2000, 95 (02) :245-250

[8]

BOLTON P, 2003, COCHRANE DB SYST REV

[9] CLINICAL-EXPERIENCE WITH A MODERN LOW-DOSE ORAL-CONTRACEPTIVE IN ALMOST 100,000 USERS [J].

BRILL, K ;

NORPOTH, T ;

SCHNITKER, J ;

ALBRING, M .

CONTRACEPTION, 1991, 43 (02) :101-110

[10] Effect of SR49059, an orally active V1a vasopressin receptor antagonist, in the prevention of dysmenorrhoea [J].

Brouard, R ;

Bossmar, T ;

Fournié-Lloret, D ;

Chassard, D ;

Åkerlund, M .

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (05) :614-619

← 1 2 3 4 5 →